If you blinked, you might have missed it. WORK Medical Technology Group Ltd (WOK) shares are having a brutal Friday, dropping over 49% to 66 cents as of this morning. The Nasdaq is down 1.65% and the S&P 500 has shed 1.18%, but WOK's move is in a league of its own.

This isn't just a bad day—it's the hangover from one of the most insane weeks in recent memory.

The Week That Was: From 24 Cents to $11.30 and Back

The Hangzhou-based medical supplier experienced a historic rally earlier this week. The stock surged 4,608.33% from a Monday low of 24 cents to a peak of $11.30 on Tuesday. Yes, you read that right—over four thousand percent in two days. Since hitting those highs, the price has trended steadily downward, and Friday's action is just the latest leg of that retreat.

Retail momentum traders, who piled in during the frenzy, are now exiting positions. The stock is experiencing a sharp hangover after the rapid ascent. Friday's move reflects cooling sentiment as investors secure gains from the news-driven spike.

What Sparked the Frenzy?

The initial rally stemmed from a deal with Shanghai Novabioplus Biotechnology Co., Ltd. This agreement focuses on a Data-Model-Application trinity. Management calls the partnership a "significant milestone" for their digital ecosystem evolution. WOK is currently developing a BioToken framework, a system that aims to digitize biopharmaceutical research and development outputs. The model mirrors their existing real-world assets (RWA) strategy. Current projects include antibody sequence optimization and enzyme molecule design.

It's the kind of news that can send a small-cap stock into orbit, especially when retail traders are hungry for the next big thing. But as quickly as it went up, it's coming down.

The Technical Picture: Still in a Deep Hole

From a trend perspective, WOK is still in a deep longer-term downtrend, with the stock down 99.99% over the past 12 months and trading well below its key moving averages. At the current level, it's trading 62.9% below its 20-day SMA ($1.73) and 53.8% below its 50-day SMA ($1.38), which keeps rallies prone to getting sold into.

Momentum is more "stabilizing than strong" right now, with RSI at 47.13—neutral and consistent with choppy, two-way trade rather than a clean rebound. For general readers, RSI is a quick way to gauge whether a move is getting stretched; readings near the middle typically mean neither buyers nor sellers have clear control.

The moving-average structure also shows why the bigger picture remains heavy: the 20-day SMA is above the 50-day SMA (a short-term bullish crossover), but the 50-day SMA is still below the 200-day SMA, which is a classic bearish long-term setup. Key turning points reinforce the volatility—RSI hit overbought in May and the stock also logged both a recent swing high and swing low in May, suggesting sharp reversals rather than steady trend.

• Key Resistance: $1.38 — near the 50-day SMA, a common area where downtrends see supply return
• Key Support: 19 cents — the 52-week low zone, a level traders often watch for capitulation risk

WOK Stock Price Activity: WORK Medical shares were down 49.23% at $0.66 at the time of publication on Friday.